Cyclopharm Limited
ASX:CYC.AX
1.56 (AUD) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Cyclopharm Limited |
Symbool | CYC.AX |
Munteenheid | AUD |
Prijs | 1.565 |
Beurswaarde | 173,929,405 |
Dividendpercentage | 0.3% |
52-weken bereik | 1.35 - 2.42 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM |
Website | https://www.cyclopharm.com |
An error occurred while fetching data.
Over Cyclopharm Limited
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)